Peter Svennilson’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$287M Buy
2020
Q2
$350M Buy
2020
Q1
$214M Buy
2019
Q4
$304M Buy
2019
Q3
$224M Buy
2019
Q2
$230M Buy